|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Tenecteplase#Drug Interactions]] |
| {{Tenecteplase}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
|
| |
|
| ==Drug Interactions==
| | [[Category: Cardiovascular Drugs]] |
| | | [[Category: Drug]] |
| Formal interaction studies of TNKase with other drugs have not been performed. Patients studied in clinical trials of TNKase were routinely treated with [[heparin]] and [[aspirin]]. Anticoagulants (such as [[heparin]] and vitamin K antagonists) and drugs that alter platelet function (such as [[acetylsalicylic acid]], [[dipyridamole]], and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after TNKase therapy.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = TNKASE (TENECTEPLASE) KIT [GENENTECH, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=69e391bf-1250-4083-aa60-6aa41c33657f | publisher = | date = | accessdate = 6 February 2014 }}</ref>
| |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Thrombolytic drugs]]
| |
| [[Category:Cardiovascular Drugs]] | |
| [[Category:Drugs]] | |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |